A

Avidity Biosciences

187 employees

Avidity Biosciences is a biotechnology company that develops oligonucleotide-based therapies for its patients.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Health Care
rare disease
RNA
drug discovery and development
Therapeutics
Pharmaceutical
nucleic acids
Life Science

Date founded

2013

Funding rounds raised

Total raised

$100M

from 12 investors over 12 rounds

A

Avidity Biosciences raised $100M on November 13, 2019

Investors: Alethea Capital Management LLC, -, Brace Pharma Capital, Perceptive Advisors, Logos Global Management, LP, RTW Investments, LP and Takeda UK Limited

A

Avidity Biosciences raised $16M on October 17, 2018

Investors: Alethea Capital Management LLC, Brace Pharma Capital, Tavistock Group, F-Prime Capital Partners and Moore Venture Partners

FAQ